|
Volumn 31, Issue 5, 2005, Pages 413-416
|
Palifermin improves oral mucositis after high dose chemotherapy and radiotherapy plus stem cell transplantation in people with haematological cancers
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CYCLOPHOSPHAMIDE;
ETOPOSIDE;
OPIATE;
PALIFERMIN;
PLACEBO;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
ADULT;
AGEUSIA;
ANUS DISEASE;
ARTHRALGIA;
AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COUGHING;
DISEASE DURATION;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG ERUPTION;
DRUG MEGADOSE;
DRUG SAFETY;
EDEMA;
ERYTHEMA;
EVIDENCE BASED MEDICINE;
FEMALE;
GRAFT VERSUS HOST REACTION;
HEMATOLOGIC MALIGNANCY;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
MAJOR CLINICAL STUDY;
MALE;
MULTIMODALITY CANCER THERAPY;
NEUROTOXICITY;
PARESTHESIA;
PRURITUS;
RANDOMIZED CONTROLLED TRIAL;
RHINITIS;
SHORT SURVEY;
STOMATITIS;
TASTE DISORDER;
THRUSH;
TREATMENT OUTCOME;
UNITED STATES;
WHOLE BODY RADIATION;
|
EID: 26444441459
PISSN: 03057372
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ctrv.2005.05.006 Document Type: Note |
Times cited : (6)
|
References (3)
|